Hormone replacement therapy - Where are we going?

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 6, 1999, Pages 1798-1812

  Santoro, Nanette F ^a   Col, Nananda F ^b   Eckman, Mark H ^b   Wong, John B ^b   Pauker, Stephen G ^b   Cauley, Jane A ^b   Zmuda, Joseph ^b   Crawford, Sybil ^b   Johannes, Catherine B ^b   Rossouw, Jacques E ^b   Merz, C Noel Bairey ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

BONE DENSITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HUMAN; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; AGED; ESTROGEN THERAPY; HEART DISEASE; MENOPAUSE; MIDDLE AGED; UNITED STATES;

AGED; BONE DENSITY; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEART DISEASES; HUMANS; MENOPAUSE; MIDDLE AGED; POSTMENOPAUSE; UNITED STATES;

EID: 0033304549     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. The Markov process in medical prognosis
2. Patient-specific decisions about hormone replacement therapy in postmenopausal women
3. Cardiovascular disease risk profiles
4. An updated coronary risk profile, A statement for health professionals
5. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually
6. Risk factors for hip fracture in white women
7. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen
8. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
9. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women
10. Hormone therapy to prevent disease and prolong life in postmenopausal women
11. Hormone replacement therapy and endometrial cancer risk: A meta-analysis
12. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
13. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART Study)
14. A convenient approximation of life expectancy (The 'DEALE') I. Validation of the method
15. A convenient approximation of life expectancy (The 'DEALE') II. Use in medical decision making
16. The Framingham Study: An epidemiological investigation of cardiovascular disease. Section 35: Survival following initial cardiovascular events. Thirty year follow-up
17. An epidemiological investigation of cardiovascular disease
18. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
19. Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo Study
20. Estrogen replacement therapy and fractures in older women
21. Diagnosis, prophylaxis, and treatment of osteoporosis
22. Cardiovascular disease in women. A special report
23. Hormone therapy to prevent disease and prolong life in postmenopausal women
24. Estrogen replacement therapy II: A prospective study in the relationship to carcinoma and cardiovascular and metabolic problems
25. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trail
26. Effects of hormone replacement therapy on fibrinolysis in postmenopausal women
27. Acute vascular effects of estrogen in postmenopausal women
28. The effect of estrogen replacement therapy on platelet aggregation and adenosine triphosphate release in postmenopausal women
29. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels